Sime Darby Oils, UKM plan liver treatment trials using palm oil extract

Sime Darby Oils MD Mohd Haris Mohd Arshad said: "The importance of developing partnerships with institutions such as the UKM is that it allows for both the development and practical implementation of our findings."

KUALA LUMPUR: Sime Darby Oils (SDO) and Universiti Kebangsaan Malaysia (UKM) will carry out clinical trials to find out if the palm oil derived Tocotrienols can be used in treating non-alcoholic fatty liver disease (NAFLD).

In a joint statement issued on Tuesday, they said this is the world’s first comprehensive clinical trial whether Tocotrienols, an antioxidant in the vitamin E family, could be used in NAFLD treatment.